Edition:
United Kingdom

Mirati Therapeutics Inc (MRTX.OQ)

MRTX.OQ on NASDAQ Stock Exchange Global Select Market

56.90USD
21 Aug 2018
Change (% chg)

$-0.05 (-0.09%)
Prev Close
$56.95
Open
$57.00
Day's High
$57.80
Day's Low
$56.08
Volume
69,905
Avg. Vol
140,721
52-wk High
$64.15
52-wk Low
$4.75

Chart for

About

Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products. The Company's clinical pipeline consists of three product candidates: MGCD265, MGCD516 and mocetinostat. MGCD265 and MGCD516 are orally-bioavailable, spectrum-selective kinase... (more)

Overall

Beta: 2.04
Market Cap(Mil.): $1,939.89
Shares Outstanding(Mil.): 32.36
Dividend: --
Yield (%): --

Financials

  MRTX.OQ Industry Sector
P/E (TTM): -- 98.72 30.39
EPS (TTM): -2.77 -- --
ROI: -46.52 0.92 12.61
ROE: -46.66 -0.89 14.80

BRIEF-Mirati Therapeutics Reports Q1 Loss Per Share $0.51

* MIRATI THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS

07 May 2018

BRIEF-Mirati Therapeutics Q4 Loss Per Share $0.67

* MIRATI THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

08 Mar 2018

Earnings vs. Estimates